A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes Mellitus
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
Phase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol Metabolism
- Status
- COMPLETED
- Phase
- PHASE2
Panitumumab in Children With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction
- Status
- COMPLETED
- Phase
- PHASE3
CAMEO: Canadian Methotrexate and Etanercept Outcome Study
- Status
- COMPLETED
- Phase
- PHASE4
Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Combining nbUVB to Etanercept in Patients
- Status
- COMPLETED
- Phase
- PHASE4
Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility
- Status
- COMPLETED
- Phase
- NA
Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint
- Status
- TERMINATED
- Phase
- PHASE2
Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216)
- Status
- COMPLETED
- Phase
- PHASE3
Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2